Suppression of KLF5 basal expression in oral carcinoma-derived cells through three intact CREB1-binding sites in the

Reiichi Katsuumi1, Tsubasa Negishi1, Kazushi Imai1

  • 1Department of Biochemistry, The Nippon Dental University School of Life Dentistry at Tokyo, Japan.

Journal of Oral Biosciences
|December 26, 2023
PubMed
Abstract

Insights

Cyclic AMP responsive element binding protein 1 (CREB1) binding to the KLF5 silencer suppresses oral cancer progression. All three CREB1-binding sites must be intact to inhibit KLF5 basal expression in oral carcinoma cells.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Regulation

Background:

  • Krüppel-like factor (KLF)5 is overexpressed in oral cancer, inhibiting epidermal differentiation and promoting carcinoma progression.
  • The regulatory mechanisms governing KLF5 gene transcription, particularly in oral cancer, remain unclear.

Purpose of the Study:

  • To investigate the transcriptional regulation of the KLF5 gene, focusing on a specific silencer region.
  • To elucidate the role of cAMP responsive element binding protein 1 (CREB1) in KLF5 gene expression in oral carcinoma cells.

Main Methods:

  • Reporter assays were used to examine the transcriptional activity of the KLF5 425-bp silencer region and its minimal essential region (MER).
  • DNA pull-down and quantitative chromatin immunoprecipitation assays assessed CREB1 binding affinity to three putative binding sites within the 425-region.
  • Reporter assays in HSC2 oral squamous carcinoma cells involved CREB1 knockdown and overexpression to evaluate the impact of binding sites on MER activity.

Main Results:

  • The 425-region suppressed MER transcriptional activity and contained three CREB1-binding sites with equal binding affinity.
  • Deletion of CREB1-binding sites reduced CREB1 precipitation and enhanced MER activity.
  • CREB1 knockdown and overexpression modulated MER activity at intact sites, with site deletion affecting this modulation.

Conclusions:

  • CREB1 binding to the KLF5 425-bp silencer region suppresses KLF5 basal expression in oral carcinoma cells.
  • Intactness of all three CREB1-binding sites is crucial for this suppression.
  • Deletion of CREB1-binding sites relieves the suppression of KLF5 basal expression, suggesting a mechanism for KLF5 regulation in oral cancer.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.1K